GlassScriptPhysician profile
Serena Brouelette
NPI 1083486187
$1,680.70
in general payments reported to CMS, 2019-2025
17 companies · $918 in 2025
The $918 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $763 · 2025: $918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,680.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $267.15 | 2024-2025 | Opzelura |
| Lilly USA, LLC | $265.95 | 2024-2025 | Olumiant, Ebglyss, Taltz |
| Abbvie INC. | $230.45 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $175.43 | 2024-2025 | Zoryve |
| Genzyme Corporation | $171.86 | 2024-2025 | |
| Amgen INC. | $105.90 | 2024 | Otezla |
| Biofrontera INC. | $97.68 | 2024-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Leo Pharma INC. | $82.60 | 2025 | Anzupgo |
| Ucb, INC. | $58.88 | 2024 | Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $48.74 | 2024-2025 | Jublia, Cabtreo |
| Galderma Laboratories, L.P. | $48.07 | 2025 | |
| Journey Medical Corporation | $24.84 | 2024 | |
| Sun Pharmaceutical Industries INC. | $23.57 | 2024 | |
| Botanix Sb INC | $23.54 | 2025 | Sofdra |
| Almirall LLC | $21.92 | 2025 | Klisyri |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.41 | 2025 | |
| Organon LLC | $16.71 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Serena Brouelette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.